Cellectar Biosciences Inc (CLRB)
3.02
-0.04
(-1.31%)
USD |
NASDAQ |
Apr 25, 11:28
Cellectar Biosciences Price: 3.02 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 3.09 | 3.175 | 3.00 | 3.06 | 1.043M |
| Apr 23, 2024 | 3.17 | 3.279 | 3.11 | 3.11 | 899197.0 |
| Apr 22, 2024 | 3.03 | 3.229 | 2.96 | 3.19 | 866660.0 |
| Apr 19, 2024 | 3.03 | 3.16 | 3.01 | 3.03 | 806967.0 |
| Apr 18, 2024 | 3.21 | 3.21 | 3.01 | 3.04 | 1.642M |
| Apr 17, 2024 | 3.32 | 3.37 | 3.165 | 3.21 | 848742.0 |
| Apr 16, 2024 | 3.28 | 3.358 | 3.23 | 3.31 | 761881.0 |
| Apr 15, 2024 | 3.51 | 3.54 | 3.28 | 3.32 | 842897.0 |
| Apr 12, 2024 | 3.69 | 3.734 | 3.475 | 3.51 | 562190.0 |
| Apr 11, 2024 | 3.49 | 3.73 | 3.49 | 3.71 | 516783.0 |
| Apr 10, 2024 | 3.66 | 3.68 | 3.45 | 3.49 | 1.133M |
| Apr 09, 2024 | 3.78 | 3.834 | 3.680 | 3.73 | 596089.0 |
| Apr 08, 2024 | 3.84 | 3.84 | 3.665 | 3.81 | 538344.0 |
| Apr 05, 2024 | 3.72 | 3.788 | 3.66 | 3.76 | 851392.0 |
| Apr 04, 2024 | 4.03 | 4.150 | 3.71 | 3.72 | 1.669M |
| Apr 03, 2024 | 4.00 | 4.02 | 3.92 | 3.98 | 620790.0 |
| Apr 02, 2024 | 3.87 | 4.045 | 3.75 | 3.99 | 1.726M |
| Apr 01, 2024 | 4.05 | 4.07 | 3.82 | 3.92 | 1.214M |
| Mar 28, 2024 | 3.83 | 4.07 | 3.79 | 3.98 | 1.769M |
| Mar 27, 2024 | 3.83 | 3.88 | 3.53 | 3.635 | 1.491M |
| Mar 26, 2024 | 3.88 | 3.99 | 3.780 | 3.85 | 668567.0 |
| Mar 25, 2024 | 4.05 | 4.17 | 3.845 | 3.87 | 1.364M |
| Mar 22, 2024 | 3.84 | 4.13 | 3.80 | 4.05 | 1.192M |
| Mar 21, 2024 | 3.80 | 3.96 | 3.76 | 3.87 | 966338.0 |
| Mar 20, 2024 | 3.80 | 3.85 | 3.60 | 3.73 | 1.355M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.27
Minimum
Dec 19 2022
31.70
Maximum
Feb 18 2020
10.12
Average
8.694
Median
Price Benchmarks
| Perspective Therapeutics Inc | 1.62 |
| Eli Lilly and Co | 724.02 |
| Actinium Pharmaceuticals Inc | 6.95 |
| Bristol-Myers Squibb Co | 44.74 |
| Altimmune Inc | 7.03 |
Price Related Metrics
| Earnings Yield | -102.6% |
| Market Cap | 97.43M |